← Leaderboards
Jaap Goudsmit
Beth Israel Deaconess Medical Center
$62,180,644
Attributed
$62,180,644
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $18.7M · FY2005–16$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$62,180,644 · 3
By mechanism
U19$62,180,644 · 3
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Norman L Letvin$50,955,616
- Michael Scott Seaman$1,441,802
- Kathryn Elaine Stephenson$9,687,291
- Hanneke Schuitemaker$2,977,506
- David Ross Kaufman$253,260
Others in their field
Top investigators on “Hiv-1”
- Barton F Haynes · Duke University$476,288,740
- Lawrence Corey · Fred Hutchinson Cancer Center$445,419,385
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$294,186,693
- Constance Ann Benson · University Of California, San Diego$272,046,180
- Peter B. Gilbert · Fred Hutchinson Cancer Center$173,010,936
- Dan H. Barouch · Fred Hutchinson Cancer Center$166,542,502
Research focus
Hiv-1VectorClinical TrialsVaccinesMonitorClinical ResearchProgramsQuality ControlAdherence (Attribute)SeroprevalencesBaseCommunicable DiseasesBiotechnologyQuality AssuranceSerotypingProductionToxicologyEnsureAdenovirusesPre-ClinicalGaggingProceduresCell LinePharmacologic Substance
Grant awards (15)
Manufacturing and Regulatory Support of Ad/MVA and Ad/Protein HIV-1 Vaccines$1,946,004
U19 · FY2016 · AI · contact PI
Manufacturing and Regulatory Support of Ad/MVA and Ad/Protein HIV-1 Vaccines$1,564,863
U19 · FY2015 · AI · contact PI
Manufacturing and Regulatory Support of Ad/MVA and Ad/Protein HIV-1 Vaccines$1,779,755
U19 · FY2014 · AI · contact PI
Manufacturing and Regulatory Support of Ad/MVA and Ad/Protein HIV-1 Vaccines$1,591,960
U19 · FY2013 · AI · contact PI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine$16,612,311
U19 · FY2012 · AI · contact PI
Manufacturing and Regulatory Support of Ad/MVA and Ad/Protein HIV-1 Vaccines$2,086,176
U19 · FY2012 · AI · contact PI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine$796,534
U19 · FY2011 · AI · contact PI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine$13,210,979
U19 · FY2010 · AI · contact PI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine$10,842,162
U19 · FY2009 · AI · contact PI
Core--Vector$22
U19 · FY2009 · AI · contact PI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine$2,669,207
U19 · FY2008 · AI · contact PI
Core--Vector$6
U19 · FY2008 · AI · contact PI
Core--Vector$1,595,516
U19 · FY2007 · AI · contact PI
Core--Vector$5,492,013
U19 · FY2006 · AI · contact PI
Core--Vector$1,993,136
U19 · FY2005 · AI